BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 30282980)

  • 21. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
    Wu SM; Li TH; Yun H; Ai HW; Zhang KH
    Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Combination of piR-823 and Eukaryotic Initiation Factor 3 B (EIF3B) Activates Hepatic Stellate Cells via Upregulating TGF-β1 in Liver Fibrogenesis.
    Tang X; Xie X; Wang X; Wang Y; Jiang X; Jiang H
    Med Sci Monit; 2018 Dec; 24():9151-9165. PubMed ID: 30556540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.
    França MER; Rocha SWS; Oliveira WH; Santos LA; de Oliveira AGV; Barbosa KPS; Nunes AKS; Rodrigues GB; Lós DB; Peixoto CA
    Inflammopharmacology; 2018 Apr; 26(2):599-609. PubMed ID: 28409388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway.
    Xiu AY; Ding Q; Li Z; Zhang CQ
    Drug Des Devel Ther; 2021; 15():3643-3659. PubMed ID: 34456560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis.
    Yang Y; Wu XQ; Li WX; Huang HM; Li HD; Pan XY; Li XF; Huang C; Meng XM; Zhang L; Lv XW; Wang H; Li J
    Oncogene; 2018 Nov; 37(47):6119-6135. PubMed ID: 29993036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation.
    Twu YC; Lee TS; Lin YL; Hsu SM; Wang YH; Liao CY; Wang CK; Liang YC; Liao YJ
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The common dietary flavonoid myricetin attenuates liver fibrosis in carbon tetrachloride treated mice.
    Geng Y; Sun Q; Li W; Lu ZM; Xu HY; Shi JS; Xu ZH
    Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27983763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PI3-kinase/Akt pathway-regulated membrane transportation of acid-sensing ion channel 1a/Calcium ion influx/endoplasmic reticulum stress activation on PDGF-induced HSC Activation.
    Zuo L; Zhu Y; Hu L; Liu Y; Wang Y; Hu Y; Wang H; Pan X; Li K; Du N; Huang Y
    J Cell Mol Med; 2019 Jun; 23(6):3940-3950. PubMed ID: 30938088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rev-erb agonist and TGF-β similarly affect autophagy but differentially regulate hepatic stellate cell fibrogenic phenotype.
    Thomes PG; Brandon-Warner E; Li T; Donohue TM; Schrum LW
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):137-147. PubMed ID: 27840152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of SEPT6 on the biological behavior of hepatic stellate cells and liver fibrosis in rats and its mechanism.
    Fan Y; Du Z; Steib CJ; Ding Q; Lu P; Tian D; Liu M
    Lab Invest; 2019 Jan; 99(1):17-36. PubMed ID: 30315255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
    Grouix B; Sarra-Bournet F; Leduc M; Simard JC; Hince K; Geerts L; Blais A; Gervais L; Laverdure A; Felton A; Richard J; Ouboudinar J; Gagnon W; Leblond FA; Laurin P; Gagnon L
    J Pharmacol Exp Ther; 2018 Oct; 367(1):71-81. PubMed ID: 30093459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increases necroinflammation and hepatic stellate cell activation but does not exacerbate experimental liver fibrosis in mice.
    Lamb CL; Cholico GN; Pu X; Hagler GD; Cornell KA; Mitchell KA
    Toxicol Appl Pharmacol; 2016 Nov; 311():42-51. PubMed ID: 27693115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnesium isoglycyrrhizinate promotes the activated hepatic stellate cells apoptosis via endoplasmic reticulum stress and ameliorates fibrogenesis in vitro and in vivo.
    Bian M; Chen X; Zhang C; Jin H; Wang F; Shao J; Chen A; Zhang F; Zheng S
    Biofactors; 2017 Nov; 43(6):836-846. PubMed ID: 29048780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
    Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of Slit2-Robo1 signaling promotes liver fibrosis.
    Chang J; Lan T; Li C; Ji X; Zheng L; Gou H; Ou Y; Wu T; Qi C; Zhang Q; Li J; Gu Q; Wen D; Cao L; Qiao L; Ding Y; Wang L
    J Hepatol; 2015 Dec; 63(6):1413-20. PubMed ID: 26264936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways.
    Wu L; Zhang Q; Mo W; Feng J; Li S; Li J; Liu T; Xu S; Wang W; Lu X; Yu Q; Chen K; Xia Y; Lu J; Xu L; Zhou Y; Fan X; Guo C
    Sci Rep; 2017 Aug; 7(1):9289. PubMed ID: 28839277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoids Have Opposing Effects on Liver Fibrosis in Hepatic Stellate and Immune Cells.
    Kim KH; Lee JM; Zhou Y; Harpavat S; Moore DD
    Mol Endocrinol; 2016 Aug; 30(8):905-16. PubMed ID: 27355192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis.
    Chen H; Gan Q; Yang C; Peng X; Qin J; Qiu S; Jiang Y; Tu S; He Y; Li S; Yang H; Tao L; Peng Y
    J Transl Med; 2019 Aug; 17(1):280. PubMed ID: 31443720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.
    Bárcena C; Stefanovic M; Tutusaus A; Joannas L; Menéndez A; García-Ruiz C; Sancho-Bru P; Marí M; Caballeria J; Rothlin CV; Fernández-Checa JC; de Frutos PG; Morales A
    J Hepatol; 2015 Sep; 63(3):670-8. PubMed ID: 25908269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivo.
    Tseng TH; Lin WL; Chen ZH; Lee YJ; Shie MS; Lee KF; Shen CH; Kuo HC
    J Transl Med; 2016 Sep; 14(1):263. PubMed ID: 27612633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.